Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

281 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Formation of gadolinium-ferritin from clinical magnetic resonance contrast agents.
Neburkova J, Rulseh AM, Chang SLY, Raabova H, Vejpravova J, Dracinsky M, Tarabek J, Kotek J, Pingle M, Majer P, Vymazal J, Cigler P. Neburkova J, et al. Among authors: vymazal j. Nanoscale Adv. 2020 Aug 31;2(12):5567-5571. doi: 10.1039/c9na00567f. eCollection 2020 Dec 15. Nanoscale Adv. 2020. PMID: 36133872 Free PMC article.
A multi-center, comparative, phase 3 study to determine the efficacy of gadofosveset-enhanced magnetic resonance angiography for evaluation of renal artery disease.
McGregor R, Vymazal J, Martinez-Lopez M, Neuwirth J, Salgado P, Beregi JP, Peduto A, de la Pena-Almaguer E, Slater GJ, Shamsi K, Parsons EC Jr. McGregor R, et al. Among authors: vymazal j. Eur J Radiol. 2008 Feb;65(2):316-25. doi: 10.1016/j.ejrad.2007.03.018. Epub 2007 May 17. Eur J Radiol. 2008. PMID: 17499952 Clinical Trial.
Are there differences between macrocyclic gadolinium contrast agents for brain tumor imaging? Results of a multicenter intraindividual crossover comparison of gadobutrol with gadoteridol (the TRUTH study).
Maravilla KR, Smith MP, Vymazal J, Goyal M, Herman M, Baima JJ, Babbel R, Vaneckova M, Žižka J, Colosimo C, Urbańczyk-Zawadzka M, Mechl M, Bag AK, Bastianello S, Bueltmann E, Hirai T, Frattini T, Kirchin MA, Pirovano G. Maravilla KR, et al. Among authors: vymazal j. AJNR Am J Neuroradiol. 2015 Jan;36(1):14-23. doi: 10.3174/ajnr.A4154. Epub 2014 Oct 9. AJNR Am J Neuroradiol. 2015. PMID: 25300984 Free PMC article. Clinical Trial.
CE-MRA of the aorta.
Vymazal J. Vymazal J. Eur Radiol. 2004 May;14 Suppl 5:M28-9. doi: 10.1007/s10406-004-0053-x. Eur Radiol. 2004. PMID: 15458000 No abstract available.
Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study).
Seidl Z, Vymazal J, Mechl M, Goyal M, Herman M, Colosimo C, Pasowicz M, Yeung R, Paraniak-Gieszczyk B, Yemen B, Anzalone N, Citterio A, Schneider G, Bastianello S, Ruscalleda J. Seidl Z, et al. Among authors: vymazal j. AJNR Am J Neuroradiol. 2012 Jun;33(6):1050-8. doi: 10.3174/ajnr.A3033. Epub 2012 Mar 1. AJNR Am J Neuroradiol. 2012. PMID: 22383237 Free PMC article. Clinical Trial.
Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for MR angiography of peripheral arteries.
Gerretsen SC, le Maire TF, Miller S, Thurnher SA, Herborn CU, Michaely HJ, Kramer H, Vanzulli A, Vymazal J, Wasser MN, Ballarati CE, Kirchin MA, Pirovano G, Leiner T. Gerretsen SC, et al. Among authors: vymazal j. Radiology. 2010 Jun;255(3):988-1000. doi: 10.1148/radiol.10090357. Radiology. 2010. PMID: 20501735 Free article. Clinical Trial.
281 results